Chapter Phar 7
PHARMACY PRACTICE
Subchapter I — General
Phar 7.03 Drug utilization review. Phar 7.04 Transferring prescription order information. Phar 7.05 Label requirements. Phar 7.06 Repackaging for stock. Phar 7.08 Patient consultation. Phar 7.085 Delivery by common carrier or delivery services. Phar 7.09 Procurement, recall and out-of-date drugs and devices. Phar 7.10 Return or exchange of health items. Phar 7.11 Pharmacy records. Phar 7.12 Delegation by a physician. Phar 7.13 Administration of drug products and devices other than vaccines. Phar 7.14 Pharmacy product verification technician-check-pharmacy
technician. Phar 7.15 Consumer disclosures. Subchapter II — Central Shared Services
Subchapter III — Delivery Systems and Remote Dispensing
Phar 7.41 Delivery system. Phar 7.42 Automated direct-to-patient dispensing system. Phar 7.43 Remote dispensing. Subchapter IV — Institutional Pharmacies
Phar 7.53 Security and access. Phar 7.54 Return or exchange of health items. Phar 7.55 Automated technology product verification. Subchapter V — Uncredentialed Pharmacy Staff
Phar 7.62 Uncredentialed pharmacy staff. Ch. Phar 7 NoteNote: Chapter Phar 7 as it existed on December 31, 2020, was repealed and a new chapter Phar 7 was created, effective January 1, 2021.
Phar 7.01Phar 7.01 Definitions. In this chapter: Phar 7.01(1)(1) “Control number” means a unique number used to identify a repackaged drug or drug product in reference to a record that contains NDC, expiration date, and lot number. Phar 7.01(2)(2) “Managing pharmacist” means a pharmacist who accepts responsibility for the operation of a pharmacy in conformance with all laws and rules pertinent to the practice of pharmacy, and who is personally in full and actual charge of the pharmacy and personnel. Phar 7.01(4)(4) “Repackaging for stock” means transferring a non-sterile drug product from the stock container in which it was distributed by the original manufacturer and placing it into a different stock container as a source for subsequent prescription dispensing without further manipulation of the drug. Phar 7.01(5)(5) “Standing order” means an order transmitted electronically or in writing by a practitioner for a drug or device that does not identify a particular patient at the time it is issued for the purpose of drug or device dispensing or administration to individuals that meet criteria of the order. Phar 7.01 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21. Phar 7.02(1)(1) Requirements. A prescription drug order shall include all of the following: Phar 7.02(1)(c)(c) Prescriptions ordered by a delegate of the practitioner shall include the first and last name of the delegate and the first and last name and address of the practitioner. Phar 7.02(1)(d)(d) Name, strength, and quantity of the drug product or device. Phar 7.02(1)(g)(g) Symptom or purpose for which the drug is being prescribed if the patient indicates in writing to the practitioner that the patient wants the symptom or purpose for the prescription to be disclosed on the label. Phar 7.02(1)(j)(j) If prescription is issued under s. 255.07 (2), Stats., the name and address of the authorized entity or individual. Phar 7.02(1)(k)(k) Practitioner’s written signature, or electronic or digital signature. Phar 7.02(2)(a)(a) A prescription pursuant to a standing order shall include all of the following:
/exec_review/admin_code/phar/7
true
administrativecode
/exec_review/admin_code/phar/7/_7
Pharmacy Examining Board (Phar)
section
true
